ZNF337

gene
On this page

Also known as dJ694B14.1

Summary

ZNF337 (zinc finger protein 337, HGNC:15809) is a protein-coding gene on chromosome 20p11.21, encoding Zinc finger protein 337 (Q9Y3M9). May be involved in transcriptional regulation.

This gene encodes a zinc finger domain containing protein. The function of this protein has yet to be determined. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 26152 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 130 total
  • MANE Select transcript: NM_015655

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15809
Approved symbolZNF337
Namezinc finger protein 337
Location20p11.21
Locus typegene with protein product
StatusApproved
AliasesdJ694B14.1
Ensembl geneENSG00000130684
Ensembl biotypeprotein_coding
Entrez26152

Gene structure

Transcript identifiers

Ensembl transcripts: 16 — 15 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000252979, ENST00000376436, ENST00000481610, ENST00000878466, ENST00000878467, ENST00000878468, ENST00000878469, ENST00000878470, ENST00000878471, ENST00000878472, ENST00000878473, ENST00000912968, ENST00000912969, ENST00000954845, ENST00000954846, ENST00000954847

RefSeq mRNA: 2 — MANE Select: NM_015655 NM_001290261, NM_015655

CCDS: CCDS13174

Canonical transcript exons

ENST00000252979 — 5 exons

ExonStartEnd
ENSE000017969642568599625686122
ENSE000018869322569675925696853
ENSE000034833332568639125686466
ENSE000035304402568556725685662
ENSE000038490822567319525677037

Expression profiles

Bgee: expression breadth ubiquitous, 286 present calls, max score 95.42.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.8143 / max 104.1237, expressed in 1721 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1868115.98561639
1868101.62861002
1868091.2001785

Top tissues by expression

296 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar hemisphereUBERON:000224595.42gold quality
cerebellar cortexUBERON:000212995.36gold quality
right hemisphere of cerebellumUBERON:001489095.35gold quality
tendon of biceps brachiiUBERON:000818894.47gold quality
cerebellumUBERON:000203794.46gold quality
cortical plateUBERON:000534393.28gold quality
right uterine tubeUBERON:000130292.66gold quality
ganglionic eminenceUBERON:000402391.18gold quality
cerebellar vermisUBERON:000472091.03gold quality
left ovaryUBERON:000211989.74gold quality
lower esophagus muscularis layerUBERON:003583389.39gold quality
lower esophagusUBERON:001347389.36gold quality
diaphragmUBERON:000110389.33gold quality
right ovaryUBERON:000211888.95gold quality
esophagogastric junction muscularis propriaUBERON:003584188.80gold quality
muscle layer of sigmoid colonUBERON:003580588.75gold quality
granulocyteCL:000009488.66gold quality
ventricular zoneUBERON:000305388.57gold quality
thymusUBERON:000237088.53gold quality
superficial temporal arteryUBERON:000161488.52gold quality
body of uterusUBERON:000985388.36gold quality
endocervixUBERON:000045888.15gold quality
embryoUBERON:000092287.88gold quality
adenohypophysisUBERON:000219687.70gold quality
ovaryUBERON:000099287.65gold quality
left uterine tubeUBERON:000130387.64gold quality
endothelial cellCL:000011587.54gold quality
pituitary glandUBERON:000000787.52gold quality
olfactory bulbUBERON:000226487.43silver quality
right frontal lobeUBERON:000281087.42gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-100618no660.89
E-ANND-3no1.51

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

73 targeting ZNF337, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-12118100.0065.881270
HSA-MIR-1193100.0065.93529
HSA-MIR-574-5P100.0066.01989
HSA-MIR-4476100.0068.182030
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-211099.9666.681930
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-130599.9171.433443
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-6857-5P99.8765.32985
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-469899.8471.414303
HSA-MIR-3180-5P99.8269.122422
HSA-MIR-807699.7868.521170
HSA-MIR-3150A-3P99.7664.441640
HSA-MIR-6763-5P99.7664.681767
HSA-MIR-471999.7372.103329
HSA-MIR-128399.6972.423009
HSA-MIR-509399.6769.262291
HSA-MIR-519A-3P99.6771.671868
HSA-MIR-519B-3P99.6771.671868
HSA-MIR-519C-3P99.6771.671870
HSA-MIR-10394-5P99.6566.831852
HSA-MIR-120599.6566.761826
HSA-MIR-450299.6566.991021
HSA-MIR-4666B99.6468.691282

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZfp78ENSMUSG00000055150
rattus_norvegicusENSRNOG00000083797
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)

Protein

Protein identifiers

Zinc finger protein 337Q9Y3M9 (reviewed: Q9Y3M9)

All UniProt accessions (1): Q9Y3M9

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9Y3M9-11yes
Q9Y3M9-22

RefSeq proteins (2): NP_001277190, NP_056470* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050758Znf_C2H2-typeFamily

Pfam: PF00096, PF01352

UniProt features (30 total): zinc finger region 20, sequence variant 2, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, cross-link 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y3M9-F175.180.07

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 458

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 79 (showing top): MORF_SNRP70, PUJANA_CHEK2_PCC_NETWORK, MODULE_205, BLALOCK_ALZHEIMERS_DISEASE_UP, MORF_PDPK1, MORF_ORC1L, MORF_MYST2, chr20p11, MORF_CNTN1, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP, IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP, CSR_EARLY_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CHAF1B_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

722 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF337PCMTD2Q9NV79470
ZNF337DRC5Q5JU00466
ZNF337ANKRA2Q9H9E1391
ZNF337PRR32B1ATL7378
ZNF337DEFB115Q30KQ5370
ZNF337TLCD2A6NGC4350
ZNF337CCDC125Q86Z20350
ZNF337ZNF518AQ6AHZ1348
ZNF337GATD1Q8NB37348
ZNF337PARP8Q8N3A8345
ZNF337ANKRD30BQ9BXX2327
ZNF337TASOR2Q5VWN6324
ZNF337TXNDC15Q96J42323
ZNF337RAB6BQ9NRW1310
ZNF337PACRGQ96M98306

IntAct

31 interactions, top by confidence:

ABTypeScore
ZNF337KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
CALCOCO2ZNF337psi-mi:“MI:0915”(physical association)0.560
MTUS2ZNF337psi-mi:“MI:0915”(physical association)0.560
KRT40ZNF337psi-mi:“MI:0915”(physical association)0.560
HMBOX1ZNF337psi-mi:“MI:0915”(physical association)0.560
RPGRIP1ZNF337psi-mi:“MI:0915”(physical association)0.560
KRTAP10-7ZNF337psi-mi:“MI:0915”(physical association)0.560
ZNF337CALCOCO2psi-mi:“MI:0915”(physical association)0.560
ZNF337RPGRIP1psi-mi:“MI:0915”(physical association)0.560
ZNF337KRT40psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF337psi-mi:“MI:0915”(physical association)0.560
GNMTZNF337psi-mi:“MI:0915”(physical association)0.560
ZNF337PTGER4psi-mi:“MI:0915”(physical association)0.370
CCDC85BZNF337psi-mi:“MI:0915”(physical association)0.370
ZNF337IPO8psi-mi:“MI:0914”(association)0.350
ZNF460ZNF320psi-mi:“MI:0914”(association)0.350
MRFAP1L1MYO9Apsi-mi:“MI:0914”(association)0.350
ZNF337CCDC125psi-mi:“MI:0915”(physical association)0.000
GNMTZNF337psi-mi:“MI:0915”(physical association)0.000
COMMD3ZNF337psi-mi:“MI:0915”(physical association)0.000

BioGRID (19): ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), RPGRIP1 (Two-hybrid), HMBOX1 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), CCDC125 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS)

ESM2 similar proteins: A6QLU5, O75820, P08043, P10076, P10755, P16374, P16415, P17014, P17021, P17027, P17039, P51786, Q08AN1, Q14588, Q3KP31, Q3ZCX4, Q52M93, Q5MCW4, Q5R5Q6, Q5R5S6, Q5R5Y7, Q5RB30, Q5REA0, Q5REI6, Q6P3V2, Q6P9Y7, Q6ZNA1, Q7TSH9, Q7TSI0, Q7Z3V5, Q80W31, Q86UE3, Q86YE8, Q8BPP0, Q8N141, Q8N4W9, Q8N9F8, Q8NDQ6, Q8TBZ5, Q96ND8

Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

130 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance125
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

534 predictions. Top by Δscore:

VariantEffectΔscore
20:25685990:GCTTA:Gdonor_loss1.0000
20:25685991:CTTA:Cdonor_loss1.0000
20:25685992:TTA:Tdonor_loss1.0000
20:25685993:TACCT:Tdonor_loss1.0000
20:25685995:C:CAdonor_loss1.0000
20:25685994:A:ACdonor_gain0.9900
20:25685995:C:CCdonor_gain0.9900
20:25686119:AAGCC:Aacceptor_loss0.9900
20:25686123:C:CAacceptor_loss0.9900
20:25686124:TGTAA:Tacceptor_loss0.9900
20:25686693:CATCA:Cdonor_gain0.9900
20:25677033:TATTC:Tacceptor_gain0.9800
20:25686125:G:Cacceptor_loss0.9800
20:25686385:TCTCA:Tdonor_loss0.9800
20:25686386:CTCAC:Cdonor_loss0.9800
20:25686387:TCACC:Tdonor_loss0.9800
20:25686388:CACC:Cdonor_loss0.9800
20:25686389:AC:Adonor_loss0.9800
20:25686390:C:CTdonor_loss0.9800
20:25677964:T:Adonor_gain0.9700
20:25686123:C:CCacceptor_gain0.9700
20:25686390:CCTGT:Cdonor_gain0.9700
20:25685995:CCTA:Cdonor_gain0.9600
20:25686035:C:Adonor_gain0.9600
20:25686692:A:ACdonor_gain0.9600
20:25686693:C:CCdonor_gain0.9600
20:25685734:C:Tacceptor_gain0.9500
20:25686121:GC:Gacceptor_gain0.9500
20:25686122:CC:Cacceptor_gain0.9500
20:25677037:CCT:Cacceptor_loss0.9400

AlphaMissense

4951 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:25676049:A:CF413L0.998
20:25676049:A:TF413L0.998
20:25676051:A:GF413L0.998
20:25675293:G:CF665L0.997
20:25675293:G:TF665L0.997
20:25675295:A:GF665L0.997
20:25675377:G:CF637L0.997
20:25675377:G:TF637L0.997
20:25675379:A:GF637L0.997
20:25675461:A:CF609L0.997
20:25675461:A:TF609L0.997
20:25675463:A:GF609L0.997
20:25675545:G:CF581L0.997
20:25675545:G:TF581L0.997
20:25675547:A:GF581L0.997
20:25675881:A:CF469L0.997
20:25675881:A:TF469L0.997
20:25675883:A:GF469L0.997
20:25675965:A:CF441L0.997
20:25675965:A:TF441L0.997
20:25675967:A:GF441L0.997
20:25676108:G:CH394D0.997
20:25676133:A:CF385L0.997
20:25676133:A:TF385L0.997
20:25676135:A:GF385L0.997
20:25676385:A:CF301L0.997
20:25676385:A:TF301L0.997
20:25676387:A:GF301L0.997
20:25675713:A:CF525L0.996
20:25675713:A:TF525L0.996

dbSNP variants (sampled 300 via entrez): RS1000259050 (20:25688111 T>C), RS1000464402 (20:25689201 G>T), RS1000505133 (20:25683234 T>G), RS1000506668 (20:25689360 C>A), RS1000563850 (20:25683635 T>G), RS1000599568 (20:25689381 C>T), RS1000679481 (20:25695575 G>A,T), RS1000903655 (20:25676192 G>A), RS1000946526 (20:25696217 C>T), RS1001167666 (20:25677409 A>G), RS1001188028 (20:25689191 C>G), RS1001302120 (20:25677648 C>G,T), RS1001389721 (20:25678212 GAAAA>G,GAAA,GAAAAA), RS1001486801 (20:25684823 C>T), RS1001516553 (20:25684496 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST006481_37Lung function (FEV1)2.000000e-07
GCST006481_6Lung function (FEV1)3.000000e-10

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004314forced expiratory volume

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects expression, decreases expression, increases expression3
Aflatoxin B1increases expression2
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
beta-lapachoneincreases expression1
perfluorooctanoic aciddecreases expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608affects binding, increases reaction1
perfluorohexanesulfonic aciddecreases expression1
PCI 5002increases expression, affects cotreatment1
Decitabineaffects expression1
Acetaminophenincreases expression1
Adeninedecreases expression1
Atrazinedecreases expression1
Benzo(a)pyreneincreases expression1
Caffeinedecreases phosphorylation1
Colchicinedecreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Hydrogen Peroxideaffects expression1
Methyl Methanesulfonateincreases expression1
Quercetinincreases expression1
Seleniumdecreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Triiodothyronineincreases expression1
Valproic Aciddecreases expression1
Vitamin Edecreases expression1
Zincaffects cotreatment, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.